Bechets disease

Reading File
Finding Sources
Searching PubMed

"Behcet disease"[MeSH Terms] AND management

Reading File
Reading File
Searching Images

Behcet disease oral ulcers skin lesions pathergy

Finding Sources
Reading File
Reading File
Reading File
Loading Image
Loading Image
Here is a comprehensive overview of Behçet Disease:

Behçet Disease (Adamantiades–Behçet Disease)

Definition & Overview

Behçet disease (BD) is a multisystem inflammatory disorder of unknown etiology, classified as a systemic vasculitis involving all types and sizes of blood vessels. It is characterized by recurrent oral aphthous ulcers, genital ulcers, skin lesions, uveitis, and arthritis, with variable involvement of vascular, GI, and neurologic systems. — Fitzpatrick's Dermatology, Ch. 141

Epidemiology

  • Prevalent along the "Silk Road" — highest rates in Turkey (80–420 per 100,000), followed by the Middle East and East Asia (Japan 14–31, Korea 35, Iran 17 per 100,000)
  • Rare in Northern Europe (0.27–1.18 per 100,000) and the USA (0.75 per 100,000)
  • Peak onset: 20s and 30s
  • Gender: largely equal overall, though male predominance persists in Arab populations; female predominance in Korea and USA

Pathogenesis

  • Genetically determined with probable environmental triggers
  • Strongly associated with HLA-B51 (especially in endemic regions)
  • Fundamental lesion: neutrophilic vascular reaction / vasculitis
  • Lymphocytic perivasculitis is also seen (often in older lesions)
  • Autoimmune dysregulation with T-cell and neutrophil hyperactivation

Clinical Features

1. Mucocutaneous (most common, usually first)

FeatureDetails
Oral aphthous ulcersRecurrent, painful; often the presenting sign; minor, major, or herpetiform types
Genital ulcersScrotum, penis, vulva, cervix; painful; often leave scars (unlike oral ulcers)
Papulopustular lesionsAcneiform; on face, neck, chest
Erythema nodosum–like lesionsTender nodules, typically on legs
PseudofolliculitisSterile pustules at hair follicles

2. Ocular

  • Uveitis (iridocyclitis / posterior uveitis) — may appear years after oral ulcers
  • Risk of blindness if untreated
  • Patients may initially report seeing spots

3. Neurological (~20%)

  • Aseptic meningitis / meningoencephalitis
  • Focal/multifocal neurological deficits — small vessel inflammatory disease; brainstem frequently involved
  • Cerebral venous sinus thrombosis
  • CSF: mild pleocytosis, elevated protein
  • Peripheral neuropathy (rare): polyneuropathy or mononeuropathy multiplex

4. Vascular

  • Venous thrombosis (DVT, Budd-Chiari)
  • Arterial aneurysms (pulmonary, aorta)
  • Pulmonary arterial aneurysm → arterio-bronchial fistula → massive hemoptysis
  • Post-anastomotic aneurysms (pathergy phenomenon)

5. Gastrointestinal

  • Abdominal pain, GI bleeding, perforation
  • Ileocecal ulcers most common (can mimic Crohn disease)

6. Articular

  • Non-destructive, asymmetric oligoarthritis of large joints (knees, ankles)

Clinical Images

Behçet Disease — oral aphthous ulcers (A), erythema nodosum-like nodules on leg (B), positive pathergy test (C)
Fig. A: Oral aphthous ulcers; B: Erythema nodosum-like leg nodules (arrows); C: Positive pathergy test at 36 h (circled)
Positive pathergy reaction — bilateral forearm crateriform ulcers after needle prick
Pathergy reaction: crateriform ulcers with central necrosis developing after needle prick — hallmark of neutrophilic hyperreactivity in BD

Diagnosis

International Criteria for Behçet Disease (ICBD Scoring System)

FeaturePoints
Ocular lesions (recurrent)2
Oral aphthosis (recurrent)2
Genital aphthosis (recurrent)2
Skin lesions (recurrent)1
CNS involvement1
Vascular manifestations1
Positive pathergy test1
Score ≥4 = Behçet DiseaseFitzpatrick's Dermatology, Table 141-1

Pathergy Test

  • Needle prick or 0.1 mL intradermal saline injection on volar forearm
  • Positive: erythematous papule/pustule >2 mm within 48 hours
  • Not pathognomonic — also seen in pyoderma gangrenosum, Crohn's, rheumatoid arthritis

Other Investigations

  • No specific serologic test; HLA-B51 supports diagnosis in appropriate context
  • Cranial MRI: hypodense/atrophic brain changes in neuro-Behçet
  • Angiography for vascular lesions
  • CSF analysis when CNS involvement suspected

Differential Diagnosis

CategoryConditions
Oculocutaneous/mucocutaneousStevens-Johnson syndrome, Reiter syndrome, Sweet syndrome, pemphigus
GI/systemicCrohn disease (most important — also has aphthae, uveitis, skin lesions), ulcerative colitis
InfectiousHSV, syphilis, HIV
Other vasculitidesSystemic lupus, polyarteritis nodosa
Differentiating from Crohn disease is particularly challenging as both share aphthous ulceration, skin lesions, and uveitis.

Treatment

ManifestationTreatment
Oral/genital ulcersTopical corticosteroids, colchicine (first-line for mucocutaneous)
Skin lesionsColchicine, dapsone
Uveitis / retinal diseaseSystemic glucocorticoids + azathioprine; cyclosporine for refractory cases
CNS involvementSystemic corticosteroids ± azathioprine; anticoagulation for cerebral venous thrombosis
Severe systemic diseaseAzathioprine, cyclophosphamide, interferon-α, anti-TNF agents (infliximab, adalimumab)
Vascular diseaseImmunosuppression + anticoagulation; surgical/endovascular for aneurysms
The primary goal in primary care is early recognition and prompt referral to ophthalmology to prevent irreversible visual loss. — Textbook of Family Medicine, 9e

Prognosis

  • Course: chronic, relapsing, progressive
  • Worse prognosis in: males, early-onset disease, HLA-B51 positivity, recurrent erythema nodosum, systemic presentations (vascular, CNS)
  • Mortality: 0–6% (mainly from vascular complications — pulmonary hemorrhage, CNS disease)
  • Mucocutaneous symptoms may improve with age; ocular disease most feared for permanent disability

Sources: Fitzpatrick's Dermatology (Ch. 141), Textbook of Family Medicine 9e, Bradley & Daroff's Neurology in Clinical Practice
This is a shared conversation. Sign in to Orris to start your own chat.